Catalent Recognized With 10 CMO Leadership Awards
SOMERSET, N.J. – February 5, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced it has won ten categories in the annual CMO Leadership Awards. The Awards, presented by Life Science Leader and based on research conducted by ISR, recognize top outsourcing partners, determined by feedback from sponsor companies who outsource manufacturing. Catalent Biologics Bloomington won six awards across the ‘Big Pharma’ categories, and Catalent Development San Diego won a further four awards in the ‘Small Pharma’ categories.
“The awards are in recognition of the highest level of accomplishment that drug development and manufacturing organizations have attained in serving the needs of their biotechnology and pharmaceutical customers and partners,” commented Louis Garguilo, Chief Editor and Conference Chair, Outsourced Pharma – Life Science Connect. “They are especially meaningful because recipients are only evaluated by the customers they have actually worked with, and include the six critical categories of capabilities, compatibility, expertise, quality, reliability and service. An award in any of these categories adds to the distinction and reputation of CMOs throughout the global drug discovery, development, manufacturing and marketing industries.”
John Chiminski, Chair and Chief Executive Officer, Catalent, added “We are honored that our investments in capabilities, expertise and technologies are being recognized by our customers.” He continued, “Ultimately, our joint mission is to help patients around the world benefit from more and better treatments.”
Further, specialty award category winners will be announced at a later date leading up to the CMO Leadership Awards Reception at The W Hotel on March 21, 2018 in NYC.
For more information on the CMO Leadership Awards visit: www.cmoleadershipawards.com.
+44 (0)7580 041073
+44 (0) 161 728 5880
Catalent, Inc. (NYSE: CTLT), is the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. With over 80 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable clinical and commercial product supply. Catalent employs over 10,000 people, including over 1,400 scientists, at more than 30 facilities across five continents, and in fiscal 2017 generated over $2 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit www.catalent.com.